Cytek Biosciences Inc expected to post earnings of 2  cents a share - Earnings Preview

Cytek Biosciences

09/08/2022 24:33

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
rise in quarterly revenue when it reports  results on August
10. 
    * The Fremont California-based  company is expected to
report  a
30.3% increase in revenue to $39.629 million from $30.41 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for earnings of 2 cents per share. For the same quarter last
year, the company reported breakeven results per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $12​, below​ its last closing price of $15.03. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.01       0.00       0.01      Beat    300
 Dec. 31 2022  0.02        0.03       0.03      Met     20
 Sep. 30 2021  0.03        0.02       0.02      Met     -14.3​
 Jun. 30 2021  0.02        0.02       0.00      Missed  -100
 ​​                                                     
                                                        ​
 This summary was machine generated August 8 at 23:33 GMT.  All
figures in US dollars  unless otherwise stated